Authors: Li Jingxin, Wang Kai DOI: 10.3760/cma.j.cn115989-20211024-00581 Published 2023-08-10 Cite as Chin J Exp Ophthalmol, 2023, 41(8): 818-821. Abstract [Download PDF] [Read Full Text] In recent years, the incidence of myopia in adolescents has been increasing year by year, and how to […]
Category: Review
Value of virtual operating system for visual behavioral assessment in mice models of visual disease
Authors: Jiao Yang, Shao Zhengbo DOI: 10.3760/cma.j.cn115989-20210524-00315 Published 2023-08-10 Cite as Chin J Exp Ophthalmol, 2023, 41(8): 822-826. Abstract [Download PDF] [Read Full Text] Visual behaviorally operant method is one of the main detections for identifying animal models of visual diseases, which […]
Research progress in the classification, diagnosis and treatment of myopic traction maculopathy
Authors: Li Shiwei, Wu Qiang DOI: 10.3760/cma.j.cn115989-20210818-00466 Published 2023-08-10 Cite as Chin J Exp Ophthalmol, 2023, 41(8): 827-832. Abstract [Download PDF] [Read Full Text] Myopic traction maculopathy (MTM) is a general term for multiple pathological changes such as myopic retinoschisis (MRS), macular […]
Role of functional magnetic resonance imaging in the functional evaluation of visual pathway in diabetic retinopathy
Authors: Meng Xiangda, Yan Hua DOI: 10.3760/cma.j.cn115989-20211130-00663 Published 2023-07-10 Cite as Chin J Exp Ophthalmol, 2023, 41(7): 683-687. Abstract [Download PDF] [Read Full Text] Diabetic retinopathy (DR), one of the microvascular complications of diabetes mellitus, is an important blinding disease in people over […]
Research status and prospect of subthreshold diode micropulse laser in the treatment of central serous chorioretinopathy
Authors: Qiao Xinrui, An Jianbin DOI: 10.3760/cma.j.cn115989-20200506-00309 Published 2023-07-10 Cite as Chin J Exp Ophthalmol, 2023, 41(7): 688-692. Abstract [Download PDF] [Read Full Text] Central serous chorioretinopathy (CSC) is a primary disease that affects the vision of young and middle-aged people.Its treatment […]
Progress in diagnosis and treatment of retinal vasoproliferative tumor
Authors: Sun Gongpeng, Chen Changzheng DOI: 10.3760/cma.j.cn115989-20200712-00488 Published 2023-07-10 Cite as Chin J Exp Ophthalmol, 2023, 41(7): 693-696. Abstract [Download PDF] [Read Full Text] Retinal vasoproliferative tumor (RVPT) is a rare benign glial proliferative tumor of unknown origin.The fundus is typically characterized […]
Application of optical coherence tomography angiography in retinal vein occlusion
Authors: Sun Jia, Yang Dongni DOI: 10.3760/cma.j.cn115989-20200918-00655 Published 2023-07-10 Cite as Chin J Exp Ophthalmol, 2023, 41(7): 697-701. Abstract [Download PDF] [Read Full Text] Retinal vein occlusion (RVO) is a common retinal vascular disease that causes painless visual impairment in clinical practice.Currently, […]
Research progress of S1P signaling pathway in eye diseases
Authors: Xia Min, Xue Jingsong, Jiang Qin DOI: 10.3760/cma.j.cn115989-20211223-00708 Published 2023-07-10 Cite as Chin J Exp Ophthalmol, 2023, 41(7): 702-707. Abstract [Download PDF] [Read Full Text] Sphingolipid metabolism is widely involved in the functional regulation of different cells, and also plays an […]
Recent advances in efficacy and safety evaluation of adalimumab in non-infectious uveitis
Authors: Guo Qi, Wang Yandong DOI: 10.3760/cma.j.cn115989-20210705-00394 Published 2023-07-10 Cite as Chin J Exp Ophthalmol, 2023, 41(7): 708-712. Abstract [Download PDF] [Read Full Text] Non-infectious uveitis (NIU) is a serious sight-threatening disease caused by chronic inflammation and its complications.First-line treatment of NIU […]
Advances in the role of vascular endothelial growth factor in the pathogenesis of posterior capsule opacification
Authors: Yan Huichao, Bao Yongzhen DOI: 10.3760/cma.j.cn115989-20200315-00168 Published 2023-06-10 Cite as Chin J Exp Ophthalmol, 2023, 41(6): 592-597. Abstract [Download PDF] [Read Full Text] Despite the continuous improvement and development of modern cataract surgery technology, posterior capsule opacification (PCO) is still the […]